HIV Treatment Studies
Bringing Together Care and Research for Better, Safer, and More Effective Treatments
HIV research studies are essential to providing critical information to help people live longer, healthier, and more comfortable lives.
Our mission has been to develop and provide the highest-quality treatment and care for people living with HIV through research.
We are part of the AIDS Clinical Trials Group (ACTG) of the National Institutes of Health (NIH). The ACTG, the largest HIV clinical-trials organization, plays a major role in defining the standards of care for treatment of HIV infection and opportunistic diseases related to HIV/AIDS around the world.
We offer a wide range of studies for people living with HIV.
REPRIEVE: Randomized Trial to Prevent Vascular Events in HIV
- Prevention of heart disease is the main goal of the study
- If you are between the ages of 40 and 75, taking anti-HIV medication for at least six months, and have no history of heart disease, you may be eligible for this study.